233 related articles for article (PubMed ID: 32323380)
1. Fear of disease progression and relevant correlates in acute leukemia patients prior to allogeneic hematopoietic stem cell transplantation.
Thiele S; Goebel S; Kröger N; Pedersen A
Psychooncology; 2020 Aug; 29(8):1248-1254. PubMed ID: 32323380
[TBL] [Abstract][Full Text] [Related]
2. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract][Full Text] [Related]
3. Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study.
Brice L; McErlean G; Donovan C; Tapp C; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I
Eur J Oncol Nurs; 2020 Dec; 49():101845. PubMed ID: 33128994
[TBL] [Abstract][Full Text] [Related]
4. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.
Melchior H; Büscher C; Thorenz A; Grochocka A; Koch U; Watzke B
Psychooncology; 2013 Jan; 22(1):39-45. PubMed ID: 21898655
[TBL] [Abstract][Full Text] [Related]
5. [Fear of progression in parents of children with cancer: adaptation of the Fear of Progression Questionnaire and correlates].
Schepper F; Abel K; Herschbach P; Christiansen H; Mehnert A; Martini J
Klin Padiatr; 2015 May; 227(3):151-6. PubMed ID: 25811743
[TBL] [Abstract][Full Text] [Related]
6. Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT.
Sarkar S; Scherwath A; Schirmer L; Schulz-Kindermann F; Neumann K; Kruse M; Dinkel A; Kunze S; Balck F; Kröger N; Koch U; Mehnert A
Bone Marrow Transplant; 2014 Sep; 49(9):1217-22. PubMed ID: 25000458
[TBL] [Abstract][Full Text] [Related]
7. Fear of progression in chronic illnesses other than cancer: a systematic review and meta-analysis of a transdiagnostic construct.
Sharpe L; Michalowski M; Richmond B; Menzies RE; Shaw J
Health Psychol Rev; 2023 Jun; 17(2):301-320. PubMed ID: 35132937
[TBL] [Abstract][Full Text] [Related]
8. Fear of cancer progression in patients with stage IA malignant melanoma.
Wagner T; Augustin M; Blome C; Forschner A; Garbe C; Gutzmer R; Hauschild A; Heinzerling L; Livingstone E; Loquai C; Schadendorf D; Terheyden P; Mueller-Brenne T; Kähler KC
Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12901. PubMed ID: 30126009
[TBL] [Abstract][Full Text] [Related]
9. Does depression decrease the moderating effect of self-efficacy in the relationship between illness perception and fear of progression in breast cancer?
Shim EJ; Lee JW; Min YH
Psychooncology; 2018 Feb; 27(2):539-547. PubMed ID: 28816370
[TBL] [Abstract][Full Text] [Related]
10. Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long-term cancer survivors.
Götze H; Taubenheim S; Dietz A; Lordick F; Mehnert-Theuerkauf A
Psychooncology; 2019 Oct; 28(10):2033-2041. PubMed ID: 31364222
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of the Fear of Progression Questionnaire for parents of children with cancer (FoP-Q-SF/PR).
Clever K; Schepper F; Pletschko T; Herschbach P; Christiansen H; Martini J
J Psychosom Res; 2018 Apr; 107():7-13. PubMed ID: 29502766
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity of fear of progression and anxiety disorders in cancer patients.
Dinkel A; Kremsreiter K; Marten-Mittag B; Lahmann C
Gen Hosp Psychiatry; 2014; 36(6):613-9. PubMed ID: 25213227
[TBL] [Abstract][Full Text] [Related]
13. Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12.
Hinz A; Mehnert A; Ernst J; Herschbach P; Schulte T
Support Care Cancer; 2015 Jun; 23(6):1579-87. PubMed ID: 25412727
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age.
Hefner J; Kapp M; Drebinger K; Dannenmann A; Einsele H; Grigoleit GU; Faller H; Csef H; Mielke S
Bone Marrow Transplant; 2014 Apr; 49(4):581-4. PubMed ID: 24442247
[TBL] [Abstract][Full Text] [Related]
15. Associations of illness perception and social support with fear of progression in young and middle-aged adults with digestive system cancer: A cross-sectional study.
Liu P; Wu Q; Cheng Y; Zhuo Y; Li Z; Ye Q; Yang Q
Eur J Oncol Nurs; 2024 Jun; 70():102586. PubMed ID: 38657348
[TBL] [Abstract][Full Text] [Related]
16. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors.
Mehnert A; Berg P; Henrich G; Herschbach P
Psychooncology; 2009 Dec; 18(12):1273-80. PubMed ID: 19267364
[TBL] [Abstract][Full Text] [Related]
17. Beyond depression, anxiety and post-traumatic stress disorder symptoms: Qualitative study of negative emotional experiences in hematopoietic stem cell transplant patients.
Amonoo HL; Brown LA; Scheu CF; Harnedy LE; Pirl WF; El-Jawahri A; Huffman JC
Eur J Cancer Care (Engl); 2020 Sep; 29(5):e13263. PubMed ID: 32469142
[TBL] [Abstract][Full Text] [Related]
18. The effect of fear of progression on quality of life among breast cancer patients: the mediating role of social support.
Ban Y; Li M; Yu M; Wu H
Health Qual Life Outcomes; 2021 Jul; 19(1):178. PubMed ID: 34253195
[TBL] [Abstract][Full Text] [Related]
19. The coping process in adults with acute leukemia undergoing hematopoietic stem cell transplantation.
Farsi Z; Nayeri ND; Negarandeh R
J Nurs Res; 2012 Jun; 20(2):99-109. PubMed ID: 22592105
[TBL] [Abstract][Full Text] [Related]
20. Relationship between fear of progression and symptom burden, disease factors and social/family factors in patients with stage-IV breast cancer in Shandong, China.
Lu Q; Liu Q; Fang S; Ma Y; Zhang B; Li H; Song L
Cancer Med; 2024 Feb; 13(4):e6749. PubMed ID: 38457242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
